Despite great strides in Medicine, we still do not understand what causes flares in patients with Ankylosing Spondylitis (AS), also known as Axial Spondyloarthropathy (AxSpA). Therefore, the only therapies available today are meant to slow down the disease, not stop it or help patients heal. Research has shown that our genetics does not define whether we are in remission or having a flare. Instead, studies have shown that our environment may play a stronger role, including evidence that specific combinations of food and gut microorganisms may contribute to the disease and its flares. The goal of this study is to better understand the root causes of AS flares.

The purpose of the study is to collect and analyze physiological, physical, and molecular data from a diverse population to increase our understanding of how such parameters are associated with postprandial glycemic response.

The goal of this study is to determine the effects of SARS-CoV-2, the virus that causes COVID-19, on general health and wellness. This brief survey asks questions about ones’ general health, symptoms one may have experienced, and nutritional habits.

The goal of this study was to understand how well customers follow their results and recommendations (R&R) to define an adherence score and to determine how adherence to Viome R&R improves general well-being.

The goal of this study was to better understand the role of the microbiome in autoimmune disease progression and the molecular features that may contribute to disease relapse (flares) and to determine if there are specific microbes found in the microbiome that may contribute to disease activity.

The goal of this study was to determine if the microbiome can be predictive of an individual’s risk to developing Type II Diabetes.

The gut microbiome has been associated with cognition as well as many different neurological diseases and disorders. This study sought to better understand the connection between the gut and the brain (the gut-brain axis).

Despite great strides in medicine, we still do not understand what causes the onset or flares of Inflammatory Bowel Disease (IBD). Many therapies available today are meant to treat the symptoms of the disease, but they are not great at disease prevention or cure. Studies have shown that our environment may play a strong role in the disease activity of IBD, including evidence that specific combinations of food and gut microorganisms may contribute to the disease and its flares. The goal of this study was to investigate the roles of nutrition and the microbiome in IBD flares.

We are privileged to work with Washington Gastroenterology (WAGI) on a unique and exciting research program whose goal is to reveal root causes of gastrointestinal diseases. While we currently treat gastrointestinal diseases, the underlying causes or triggers for these conditions are not understood. Even though this study is purely observational (there is no treatment provided), the knowledge gained should enable improved preventative measures in the future, especially those focused on nutrition.

Our diet and microbiome, and their interactions with genetic and other factors, play a crucial role in the onset and progression of many of these chronic diseases, including cancer. The goal of this study is to understand these complex cause-effect relationships, then develop treatments to PREVENT, CURE, AND ELIMINATE these conditions. To do this, we need your help. 

This study only accepts current and upcoming patients of Washington Gastroenterology (WAGI).

To thank you, you will receive a $50 Amazon gift card for the first set of samples you provide. If we ask you to provide a second set of samples, you will also receive personalized nutritional recommendations based on your test results.

Viome is developing a novel vaginal microbiome test. To better understand what microorganisms are present in vaginal samples, and what they are doing we have launched a study seeking to investigate the vaginal microbiome in a large and diverse population.

This is a collaborative study with the University of Sydney that is recruiting patients in Auckland, New Zealand. The purpose of this study is to gather detailed information about digestive function, gut bacteria and their by-products as well as a range of symptoms affecting women with fibromyalgia and compare them to women without fibromyalgia. This study is only recruiting adult women who are either healthy or meet ACR2016 criteria for fibromyalgia and age & gender-matched controls.

The goal of this research study is to identify the root causes of colorectal cancer (CRC) onset and progression. Despite great strides in medicine and cancer therapy, there are no effective preventative therapies. Research has shown that our genetics plays a minor role in the CRC onset and progression; the major role is played by the gut microbiome, our immune system and nutrition. However, the specific combination of nutrients, inflammatory signals and gut microbes that can cause CRC has not been identified. In this study, participants will be followed from cancer diagnosis for several years. During this time, several samples (stool, blood, saliva, urine, and tissue biopsies) will be collected at multiple time points. These samples will be analyzed using metatranscriptomic, genomic, and proteomic methods to generate vast amounts of data about each participant’s physiology, with the specific focus on microbiome-human interactions. All medical records will also be collected. Machine learning will be used to identify human and microbial determinants of CRC onset and progression.

The study is only recruiting patients at specific study sites.